SCHEMBL18166394

SCHEMBL18166394

Cc1ccc(-c2cc(OC(=O)NC(C)c3ccncc3)cc(-n3nnnc3C(C)C)c2)c(F)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 2/20 0.38
RPS6KA5 O75582 1/20 0.38
MAP4K4 O95819 1/20 0.38
PRKCG P05129 1/20 0.38
CDK1 P06493 1/20 0.38
PRKACA P17612 1/20 0.38
RPS6KB1 P23443 1/20 0.38
CDK2 P24941 1/20 0.38
MAPK1 P28482 1/20 0.38
AKT1 P31749 1/20 0.38
AKT2 P31751 1/20 0.38
FLT4 P35916 1/20 0.38
GSK3A P49840 1/20 0.38
GSK3B P49841 1/20 0.38
IRAK1 P51617 1/20 0.38
RPS6KA3 P51812 1/20 0.38
PRKX P51817 1/20 0.38
NEK4 P51957 1/20 0.38
CDK5 Q00535 1/20 0.38
PRKCD Q05655 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18166460 0.91 AKR1C3 (0.38) ROCK1RPS6KA5MAP4K4PRKCGCDK1
SCHEMBL18166340 0.90 LMNA (0.36) ROCK1RPS6KA5PRKACARPS6KB1CDK2
SCHEMBL18166352 0.88 P2RX3 (0.40) ROCK1RPS6KA5MAP4K4PRKCGCDK1
SCHEMBL18166284 0.88 MAP3K5 (0.35) P2RX3P2RX2MAP3K5
SCHEMBL18166380 0.87 P2RX3 (0.48) P2RX3P2RX2
SCHEMBL18166349 0.87 P2RX3 (0.48) P2RX3P2RX2
SCHEMBL10244895 0.87 P2RX3 (0.47) ROCK1RPS6KA5MAP4K4PRKCGCDK1
SCHEMBL18166269 0.86 P2RX3 (0.38) MAPK1P2RX3P2RX2MAP3K5CTSA
SCHEMBL18166366 0.86 P2RX3 (0.36) ROCK1RPS6KA5MAP4K4PRKCGCDK1
SCHEMBL18166455 0.86 FAAH (0.42) CDK2GSK3BLMNACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038264-B1 TETRAZOLE-SUBSTITUTED ARYLAMIDES HOFFMANN LA ROCHE (CH) 2016-10-26 EP claimed